Angela Kill

1.3k total citations
8 papers, 549 citations indexed

About

Angela Kill is a scholar working on Pathology and Forensic Medicine, Immunology and Rheumatology. According to data from OpenAlex, Angela Kill has authored 8 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Immunology and 4 papers in Rheumatology. Recurrent topics in Angela Kill's work include Systemic Sclerosis and Related Diseases (7 papers), Mast cells and histamine (6 papers) and Urticaria and Related Conditions (4 papers). Angela Kill is often cited by papers focused on Systemic Sclerosis and Related Diseases (7 papers), Mast cells and histamine (6 papers) and Urticaria and Related Conditions (4 papers). Angela Kill collaborates with scholars based in Germany, Croatia and Italy. Angela Kill's co-authors include Gabriela Riemekasten, Mike Oliver Becker, Duska Dragun, Harald Heidecke, Jeannine Günther, Mislav Radić, Gerd R Burmester, Gerd‐Rüdiger Burmester, B. Hegner and Rusan Catar and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

Angela Kill

8 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Kill Germany 7 308 209 143 109 103 8 549
G. Mazzola Italy 14 127 0.4× 215 1.0× 59 0.4× 135 1.2× 77 0.7× 40 607
Andreu Fernández‐Codina Spain 13 374 1.2× 128 0.6× 307 2.1× 207 1.9× 279 2.7× 43 710
C.P. Denton United Kingdom 11 461 1.5× 160 0.8× 128 0.9× 173 1.6× 114 1.1× 28 620
Sabrina Hoa Canada 12 229 0.7× 93 0.4× 140 1.0× 124 1.1× 71 0.7× 24 397
Maria Edvige Fasano Italy 9 139 0.5× 69 0.3× 41 0.3× 29 0.3× 13 0.1× 15 375
Katherine M. Jasnosz United States 10 85 0.3× 26 0.1× 47 0.3× 54 0.5× 33 0.3× 16 392
Wick Mr United States 12 40 0.1× 35 0.2× 137 1.0× 65 0.6× 43 0.4× 29 480
Yuri Masui Japan 14 230 0.7× 131 0.6× 102 0.7× 71 0.7× 55 0.5× 30 452
Monica Caronni Italy 14 406 1.3× 184 0.9× 74 0.5× 220 2.0× 134 1.3× 17 615
Ruth Klaasen Netherlands 9 60 0.2× 78 0.4× 69 0.5× 22 0.2× 343 3.3× 26 509

Countries citing papers authored by Angela Kill

Since Specialization
Citations

This map shows the geographic impact of Angela Kill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Kill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Kill more than expected).

Fields of papers citing papers by Angela Kill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Kill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Kill. The network helps show where Angela Kill may publish in the future.

Co-authorship network of co-authors of Angela Kill

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Kill. A scholar is included among the top collaborators of Angela Kill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Kill. Angela Kill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Catar, Rusan, Nan Zhu, Angelika Kusch, et al.. (2021). Autoantibodies Targeting AT1- and ETA-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor. International Journal of Molecular Sciences. 23(1). 244–244. 11 indexed citations
2.
Rademacher, Judith, Angela Kill, Duska Dragun, et al.. (2016). Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18. The Journal of Rheumatology. 43(3). 587–591. 12 indexed citations
3.
Kill, Angela & Gabriela Riemekasten. (2015). Functional Autoantibodies in Systemic Sclerosis Pathogenesis. Current Rheumatology Reports. 17(5). 34–34. 24 indexed citations
4.
Günther, Jeannine, Angela Kill, Mike Oliver Becker, et al.. (2014). Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients. Arthritis Research & Therapy. 16(2). R65–R65. 86 indexed citations
5.
Kill, Angela, Christoph Tabeling, Reinmar Undeutsch, et al.. (2014). Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Research & Therapy. 16(1). R29–R29. 118 indexed citations
6.
Kill, Angela, et al.. (2012). Anti-AT(1)R and anti-ET(A)R autoantibodies in systemic sclerosis: clues for possible involvement in disease pathology. Annals of the Rheumatic Diseases. 71. A39–A39. 1 indexed citations
7.
Riemekasten, Gabriela, Aurélie Philippe, Torsten Slowinski, et al.. (2010). Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Annals of the Rheumatic Diseases. 70(3). 530–536. 212 indexed citations
8.
Hanke, Katharina, Claudia Brückner, Cornelia Dähnrich, et al.. (2009). Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Research & Therapy. 11(1). R22–R22. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026